Gao Hanlin 4
4 · Fulgent Genetics, Inc. · Filed Apr 28, 2026
Research Summary
AI-generated summary of this filing
Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 1,645 Shares
What Happened Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), had 1,645 shares disposed (withheld) to satisfy tax withholding obligations that arose when certain restricted stock units (RSUs) vested. The withholding was recorded at $16.31 per share for a total value of approximately $26,830. This was a tax-withholding disposition (code F), not an open-market sale initiated to generate cash.
Key Details
- Transaction date: 2026-04-26; Filing date: 2026-04-28 (filing appears timely).
- Disposition: 1,645 shares at $16.31 per share; total value ≈ $26,830.
- Transaction code: F (shares withheld to cover tax liability).
- Shares owned after the transaction: not specified in this filing.
- Footnote: These shares were withheld upon vesting of RSUs assumed under the merger Agreement and Plan of Merger dated Nov 7, 2022; the awards were originally reported on Form 4 filed Nov 9, 2022.
Context This is a routine tax-withholding event tied to RSU vesting (a common administrative disposition) rather than a discretionary sale or purchase. Such withholdings reduce the insider's net share count but do not necessarily signal a change in the insider's view of the company.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-04-26$16.31/sh−1,645$26,830→ 993,007 total
Footnotes (1)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.